Riverwater Partners’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
Riverwater Partners's LMAT Position: Q2 2026 in Review
Riverwater Partners increased its LeMaitre Vascular (LMAT) stake by 1.4% in Q2 2026, buying an estimated $33K and bringing the position to 22,593 shares worth $2.17M. The position accounts for 0.64% of the portfolio, ranked #54.
Riverwater Partners first reported a position in LMAT in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.89M in Q3 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Riverwater Partners held 22,593 shares of LeMaitre Vascular worth $2.17M as of Q2 2026.
- Riverwater Partners bought 322 LeMaitre Vascular shares in Q2 2026, an estimated $33K.
- LeMaitre Vascular made up 0.64% of Riverwater Partners's portfolio in Q2 2026, its #54 holding.
- Riverwater Partners first reported a position in LeMaitre Vascular in Q1 2022 and has held it in 18 quarters since.
- Riverwater Partners's LeMaitre Vascular position peaked at $2.89M in Q3 2024.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Riverwater Partners's 13F filing for Q2 2026, filed 14 Aug 2026.